Simplex Trading’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.28M | Buy |
4,300
+2,900
| +207% | +$939K | ﹤0.01% | 2245 |
|
|
2025
Q4 | $425K | Sell |
1,400
-1,000
| -42% | -$327K | ﹤0.01% | 3462 |
|
|
2025
Q3 | $817K | Buy |
2,400
+2,100
| +700% | +$638K | ﹤0.01% | 3259 |
|
|
2025
Q2 | $72K | Buy |
+300
| New | +$73.6K | ﹤0.01% | 5562 |
|
|
2025
Q1 | – | Sell |
-1,900
| Closed | -$10K | – | 9937 |
|
|
2024
Q4 | $10K | Sell |
1,900
-500
| -21% | -$102K | ﹤0.01% | 7231 |
|
|
2024
Q3 | $538K | Buy |
2,400
+2,000
| +500% | +$360K | ﹤0.01% | 3516 |
|
|
2024
Q2 | $57K | Sell |
400
-1,800
| -82% | -$277K | ﹤0.01% | 5957 |
|
|
2024
Q1 | $344K | Buy |
2,200
+2,000
| +1,000% | +$322K | ﹤0.01% | 4239 |
|
|
2023
Q4 | $36K | Sell |
200
-1,000
| -83% | -$181K | ﹤0.01% | 6405 |
|
|
2023
Q3 | $215K | Sell |
1,200
-8,500
| -88% | -$1.68M | ﹤0.01% | 4266 |
|
|
2023
Q2 | $1.73M | Sell |
9,700
-1,600
| -14% | -$368K | ﹤0.01% | 2086 |
|
|
2023
Q1 | $2.44M | Buy |
11,300
+10,000
| +769% | +$2.4M | ﹤0.01% | 1782 |
|
|
2022
Q4 | $285K | Buy |
1,300
+900
| +225% | +$165K | ﹤0.01% | 3804 |
|
|
2022
Q3 | $53K | Buy |
400
+100
| +33% | +$17.2K | ﹤0.01% | 6384 |
|
|
2022
Q2 | $48K | Sell |
300
-1,900
| -86% | -$297K | ﹤0.01% | 6565 |
|
|
2022
Q1 | $414K | Buy |
2,200
+400
| +22% | +$85K | ﹤0.01% | 4093 |
|
|
2021
Q4 | $487K | Buy |
1,800
+1,200
| +200% | +$405K | ﹤0.01% | 3845 |
|
|
2021
Q3 | $209K | Hold |
600
| – | – | ﹤0.01% | 5528 |
|
|
2021
Q2 | $205K | Buy |
600
+597
| +19,900% | +$198K | ﹤0.01% | 5646 |
|
|
2021
Q1 | $104K | Hold |
3
| – | – | ﹤0.01% | 5705 |
|
|
2020
Q4 | $77K | Hold |
3
| – | – | ﹤0.01% | 5710 |
|
|
2020
Q3 | $85K | Buy |
3
+2
| +200% | +$470 | ﹤0.01% | 5082 |
|
|
2020
Q2 | $18K | Sell |
1
-3
| -75% | -$488 | ﹤0.01% | 6307 |
|
|
2020
Q1 | $49K | Sell |
4
-17
| -81% | -$2.66K | ﹤0.01% | 5156 |
|
|
2019
Q4 | $348K | Buy |
21
+2
| +11% | +$332 | ﹤0.01% | 3121 |
|
|
2019
Q3 | $232K | Sell |
19
-32
| -63% | -$4.25K | ﹤0.01% | 3408 |
|
|
2019
Q2 | $632K | Buy |
51
+41
| +410% | +$5.2K | ﹤0.01% | 2356 |
|
|
2019
Q1 | $132K | Sell |
10
-48
| -83% | -$6.48K | ﹤0.01% | 4057 |
|
|
2018
Q4 | $813K | Buy |
58
+54
| +1,350% | +$7.16K | ﹤0.01% | 1806 |
|
|
2018
Q3 | $68K | Sell |
4
-19
| -83% | -$3.19K | ﹤0.01% | 4855 |
|
|
2018
Q2 | $353K | Sell |
23
-216
| -90% | -$38.5K | ﹤0.01% | 2830 |
|
|
2018
Q1 | $312K | Buy |
239
+227
| +1,892% | +$30.7K | 0.01% | 967 |
|
|
2017
Q4 | $30K | Buy |
12
+3
| +33% | +$275 | ﹤0.01% | 2935 |
|
|
2017
Q3 | $24K | Buy |
+9
| New | +$671 | ﹤0.01% | 3000 |
|
Other funds holding ONC
BBA
HA
Simplex Trading's ONC Position: Q3 2025 in Review
Simplex Trading sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 503 shares — an estimated $153K sold.
Simplex Trading first reported a position in ONC in Q3 2017 and held it in 21 quarters. The position peaked at $1.28M in Q3 2020. 265 funds tracked by Wall St. Rank hold ONC as of Q3 2025.
- Simplex Trading reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 503 BeOne Medicines Ltd shares in Q3 2025, an estimated $153K.
- Simplex Trading first reported a position in BeOne Medicines Ltd in Q3 2017 and held it in 21 quarters.
- Simplex Trading's BeOne Medicines Ltd position peaked at $1.28M in Q3 2020.
- 265 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.